Laboratorios Farma | ROVI - Interest Expense On Debt


Laboratorios Farma reported EUR699K in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 4.83M 359.32M Dec/2025
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 0 Dec/2025
IQVIA Holdings USD 193M 4M Dec/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Moderna USD 12.14B 12.13B Sep/2025
Organon & Co USD 128M 3M Sep/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Revvity USD 23.51M 742K Dec/2025
Tectonic Therapeutic USD 12K 276.99M Dec/2025
Viatris USD 119.6M 0 Dec/2025
Xeris Pharmaceuticals USD 7.15M 115K Dec/2025